BBIO 51.83 ▼ -0.02% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BridgeBio Pharma Inc.

    NASDAQ: BBIO · Real-Time Price · USD
    51.83
    -0.01 (-0.02%)
    At close: Sep 04, 2025, 3:59 PM
    51.04
    -1.52%
    After-hours: Sep 04, 2025, 07:28 PM EDT
    -0.02%
    Bid 50
    Market Cap 9.91B
    Revenue (ttm) 235.81M
    Net Income (ttm) -776.41M
    EPS (ttm) -4.13
    PE Ratio (ttm) -12.55
    Forward PE -27.78
    Analyst Buy
    Ask 52.75
    Volume 2,190,811
    Avg. Volume (20D) 2,888,775
    Open 51.97
    Previous Close 51.84
    Day's Range 50.49 - 52.44
    52-Week Range 21.72 - 52.84
    Beta 1.23

    About BBIO

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol BBIO
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for BBIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    BridgeBio Pharma Inc. is scheduled to release its earnings on Nov 11, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription
    4 weeks ago
    -8.94%
    BridgeBio Pharma shares are trading lower after th... Unlock content with Pro Subscription
    1 month ago
    +3.06%
    BridgeBio Pharma shares are trading lower after the company reported worse-than-expected Q2 EPS results.

    2 weeks ago · youtube.com

    ‘BUY THAT THING': Historically undervalued stock now has value, says wealth expert

    Aquinas Wealth Advisors CEO Chris McMahon discusses the state of the economy, the success of healthcare stocks and more on ‘Making Money.' #foxbusiness #fox #usa #us #news #breakingnews #MakingMoney #...

    news image

    3 weeks ago · seekingalpha.com

    BridgeBio Pharma, Inc. (BBIO) Q2 2025 Earnings Call Transcript

    BridgeBio Pharma, Inc. (NASDAQ:BBIO ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Ananth Sridhar - Chief Operating Officer Chinmay Shukla - VP IR & Strategic Financ...

    news image

    1 month ago · zacks.com

    BridgeBio Pharma (BBIO) Reports Q2 Loss, Beats Revenue Estimates

    BridgeBio Pharma (BBIO) came out with a quarterly loss of $0.95 per share versus the Zacks Consensus Estimate of a loss of $0.83. This compares to a loss of $1.02 per share a year ago.

    news image

    1 month ago · zacks.com

    BridgeBio Pharma (BBIO) Expected to Beat Earnings Estimates: Should You Buy?

    BridgeBio Pharma (BBIO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    1 month ago · youtube.com

    It is time for a move higher in biotech, says Mizuho's Jared Holz

    Jared Holz, Mizuho, joins 'Closing Bell Overtime' to discuss if the biotech sector is ready for a breakout.

    news image

    3 months ago · seekingalpha.com

    BridgeBio: New Data Bolsters The Bull Case

    BridgeBio's Attruby launch crushed expectations, with Q1 revenue triple analyst estimates, driven by higher-than-expected conversion rates and minimal free trial usage. Competitive threats from Amvutt...

    Add to Watchlist